Article
Osteosarcoma – conventional treatment vs. gene therapy
15 Jan 2009
Abstract excerpt
Osteosarcoma (OS) remains the most common primary malignant bone cancer affecting children and adolescents. Majority of patients are subjected to surgery and chemotherapy with limited alternatives to consider. However, with increasing knowledge of the molecular pathogenesis of OS, advancements in OS therapy research fields have developed potential agents for a more targeted and localised approach to treatment....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
